Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review

Immune checkpoint inhibitors (ICIs) are drugs growingly employed in the treatment of cancers, but there are still uncertainties about their possible role in the risk of developing nontuberculous mycobacteria (NTM) infections. To understand this, we performed a systematic review of the literature inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Andrea, Gramegna, Andrea, Ori, Margherita, Azzarà, Cecilia, Blasi, Francesco, Gori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703143/
https://www.ncbi.nlm.nih.gov/pubmed/36451841
http://dx.doi.org/10.1183/23120541.00364-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703143/
https://www.ncbi.nlm.nih.gov/pubmed/36451841
http://dx.doi.org/10.1183/23120541.00364-2022

Ejemplares similares